Fibromyalgia is a chronic discomfort syndrome, characterized by chronic musculoskeletal discomfort, fatigue, and mood disturbances. There are practically no information on the impact of health-related cannabis (MC) remedy on sufferers with fibromyalgia.
Information have been obtained from the registries of two hospitals in Israel (Laniado Hospital and Nazareth Hospital) on sufferers with a diagnosis of fibromyalgia who have been treated with MC. Following getting patient consent, demographic, clinical, and laboratory parameters have been documented. All the sufferers also completed the Revised Fibromyalgia Influence Questionnaire relating to the period prior to and just after MC remedy.
Thirty sufferers have been identified, and 26 sufferers have been integrated in the study. There have been 19 female sufferers (73%), and the imply age of the study group was 37.eight ± 7.six years. The imply dosage of MC was 26 ± eight.three g per month, and the imply duration of MC use was 10.four ± 11.three months. Following commencing MC remedy, all the sufferers reported a substantial improvement in just about every parameter on the questionnaire, and 13 sufferers (50%) stopped taking any other medicines for fibromyalgia. Eight sufferers (30%) seasoned really mild adverse effects.
Healthcare cannabis treatment had a substantial favorable impact on sufferers with fibromyalgia, with handful of adverse effects.